期刊文献+

苯丙酮尿症儿童脑部病变常规MRI及^1H-MRS研究 被引量:1

Diagnostic Value of Conventional MRI and ~1H-MRS in Brain Lesions Caused by PKU in Children
原文传递
导出
摘要 目的采用磁共振质子波谱成像(1H-MRS)研究苯丙酮尿症(phenylketonuria,PKU)患儿脑白质内病灶的代谢特点,并观察不同白质病变区代谢的变化。资料与方法对8例临床确诊的PKU患儿及性别、年龄相匹配的8名健康儿童(对照组)分别行T1WI自旋回波序列(SE)、T2WI快速自旋回波序列(FSE)及液体衰减反转恢复序列(FLAIR)检查。1H-MRS检查选择侧脑室后角T2WI异常信号区及放射冠正常白质为兴趣区(ROI),测量1H-MRS谱线上氮-乙酰天门冬氨酸(NAA)、胆碱(Cho)及肌酸(Cr)等主要共振峰的面积,并计算下列化合物的比值:NAA/Cr、Cho/Cr、1000*NAA(Cho、Cr)/H2O。结果在T2WI上,所有未经治疗的PKU患儿侧脑室后角周围白质均可见非占位性、斑片状、条带状高信号。1H-MRS显示未经治疗及治疗后PKU白质异常区及放射冠诸代谢产物与正常对照组差异无统计学意义(P>0.05)。结论 MRS可作为无创性研究PKU病理生理过程的方法。 Objective To investigate the features of conventional MRI and 1H-MRS in the brain lesions caused by PKU in children.Materials and Methods Eight patients with PKU and 8 age-and sex-matched health volunteers underwent MRI,included T1WI,T2WI,fluid-attenuated inversion recovery(FLAIR),and 1H-MRS examination.The white matter around the posterior horn of lateral ventricle and in coronal radiation were selected as region of interest(ROI).Cerebral metabolites,included choline/cretine,NAA/cretine,in the ROI were calculated.Results Patchy areas of hyper intensity signal on T2WI were located symmetrically in the parieto-occipital white matter in all untreated PKU.MRS metabolites in the ROI had no significant difference between PKU patients and controls(P〉0.05).Conclusion 1H-MRS as a noninvasive method can indicate the neuronal damage in lesions,and help to understand the pathophysiological process of PKU.
出处 《临床放射学杂志》 CSCD 北大核心 2011年第10期1515-1518,共4页 Journal of Clinical Radiology
关键词 苯丙酮尿症 磁共振波谱成像 Phenylketonuria Magnetic resonance spectroscopy Brain
  • 相关文献

参考文献3

二级参考文献46

  • 1陈国庆,田媛.苯丙酮尿症48例[J].实用儿科临床杂志,2006,21(8):483-484. 被引量:9
  • 2王啸,余永强,钱银锋,潘义广,徐家声,吴宗山,彭传勇,李康.苯丙酮尿症儿童脑部磁共振成像与临床生化的相关性[J].实用儿科临床杂志,2007,22(8):617-618. 被引量:2
  • 3Leuzzi V, Bianchi MC, Tosetti M, et al. Clinical significance of brain phenylalanine concentration assessed by in vivo proton magnetic resonance spectroscopy in phenylketonuria. J Inherit Metab Dis, 2000, 23: 563-570.
  • 4Moiler HE, Vermathen P, Ullrich K, et al. In-vivo NMR spectroscopy in patients with phenylketonuria: changes of cerebral phenylalanine levels under dietary. Neuropediatrics, 1995, 26 : 199-202.
  • 5Ross BD, Freeman DM, Chart L. Phosphorous metabolites by NMR. Adv Exp Med Biol, 1984, 178: 455-464.
  • 6Avison MJ, Herschkowitz N, Novotny E J, et al. Proton NMR observation of phenylalanine and an aromatic metabolite in the rabbit brain in vivo. Pediatr Res, 1990, 27: 566-570.
  • 7Kreis R, Pietz J, Penzien J, et al. Identification and quantification of phenylalanine in the brain of patients with phenylketonuria by means of localized in vivo I H magnetic resonance spectroscopy. J Magn Reson B,1995, 107: 242-251.
  • 8Novotny E J, Avison M J, Herschkowetz N, et al. In vivo measurement of phenylalanine in human brain by proton magnetic resonance spectroscopy. Pediatr Res, 1995, 37: 244-249.
  • 9Kamada K, Houkin K, Hida K, et al. In vivo proton magnetic resonance spectroscopy for metabolic changes of human brain edema. Neurol Med Chir (Tokyo), 1994, 34: 676-681.
  • 10Sijens PE, Oudkerk M. 1H chemical shift imaging characterization of human brain tumor and edema. Eur Radiol, 2002, 12: 2056- 2061.

共引文献8

同被引文献2

引证文献1

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部